Scienmag

OCTOBER 19, 2020

New research led by University of Hawai’i at Manoa scientists revealed that, in the mutually beneficial […]. It is now recognized that microbiomes are major drivers of health in all animals, including humans, and that these symbiotic systems often exhibit strong daily rhythms.

Bacteria 52

Bacteria Protein Scientist Research 52

The Pharma Data

JUNE 30, 2021

For their remarkable scientific contributions, doctoral student Julia Klaus, Zurich University VetSuisse Faculty, and Dr Yasmin Parr from the MRC-University of Glasgow, Centre for Virus Research, have received the 2021 ABCD Young Scientist Award. To foster young talent development in the feline health research community.

Scientist 52

Scientist Immune Response Antibody Development 52

XTalks

FEBRUARY 11, 2021

Much of the fundamental groundwork for genetics and genomic research was laid in the 20 th century, with significant contributions from women scientists, some of whom worked during times when acceptance of female researchers was not widespread. Rosalind Franklin: From Chemistry to Genetics.

Genetics 119

Genetics DNA Genome Genomics 119

Drug Discovery World

JULY 29, 2022

But with hundreds of bacterial species populating our gastrointestinal tract, it’s a daunting task to pinpoint which molecules made by which bacteria affect which biological processes—and how they do so. Such knowledge is essential for learning how to manipulate gut bacteria to treat or prevent illness. muciniphila’s cell membrane.

Bacterium 52

Bacterium Research Bacteria Immune Response 52

XTalks

JANUARY 6, 2021

Researchers at the National Institutes of Health (NIH) in the US have isolated small antibodies called “nanobodies” from a llama named Cormac that can block the SARS-CoV-2 coronavirus. Related: Scientists Use Llama Antibodies to Neutralize COVID-19. Several groups have been researching nanobodies as treatment options for COVID-19.

Antibody 105

Antibody Protein Bacteria In-Vitro 105

Delveinsight

JANUARY 28, 2021

Nirogy plans to use the proceeds to improve its drug discovery platform for generating a pipeline of small-molecule drugs designed to aim the solute carrier family of transporter proteins (SLCTs) embedded in the cell membrane. Gut Bacteria proffer insight into molecules protective against asthma and COVID-19.

Bacteria 52

Bacteria Trials Drugs Clinical Trials 52

Drug Discovery World

AUGUST 9, 2022

Based in Dundee, Cypex manufactures recombinant xenobiotic metabolizing enzymes with its product portfolio covering a wide range of proteins involved in drug metabolism. . This technology enables the expression of human drug-metabolizing enzymes in bacteria, without requiring large modifications to the proteins.?

In-Vitro 52

In-Vitro Protein Production Bacteria 52

The Pharma Data

JUNE 22, 2023

They have shown that the mechanism involves a block in proteins called interferons, which promote tissue factor releases. ” The team demonstrated that life-threatening clotting could be prevented in mice infected with the bacteria E. coli and Staph aureus and also in response to SARS-CoV2, the virus that causes COVID-19.

Bacteria 40

Bacteria Branding Protein Scientist 40

Drug Discovery World

NOVEMBER 17, 2022

Applying the principles of engineering to biology – redesigning organisms and biological parts to create synthetic components with new abilities – fuels the progression of medicine and gives researchers additional ability to tackle scientific issues. . It appears to neutralise even drug-resistant bacteria. .

Bacteria 52

Bacteria Engineer Gene Genetics 52

XTalks

NOVEMBER 9, 2021

Over the last year, researchers have been studying the effectiveness of RNA-based pesticides, and there are already a handful of sprays in the works. Ever since pesticides became widely used in agriculture, scientists have been searching for ways to improve upon pest protection for both human and planetary health.

RNA 98

RNA Gene Scientist Protein 98

XTalks

JANUARY 20, 2021

Researchers at KU Leuven in Belgium have found a potential mechanism underlying irritable bowel syndrome (IBS) that involves activation of immune cells primed by past gastrointestinal infections. The research findings were published in the journal Nature. Related: Monitoring Patients with IBS or Kidney Failure?

Immune Response 52

Immune Response Research Allergies Protein 52

Drug Discovery World

DECEMBER 14, 2023

The new hub will become a part of the already thriving life sciences sector in the Glasgow area, most of which is centred around the university, the Cancer Research UK Scotland Institute and the BioCity cluster, making Glasgow and its surrounds one of the most important regions for drug discovery and development in the UK.

Drugs 75

Drugs Life Science Research Scientist 75

The Pharma Data

MARCH 13, 2022

That’s because the mutations that led to the variant’s emergence aren’t found in the regions of the virus that stimulates one type of cellular immune response, says an international research team from Johns Hopkins Medicine, in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and ImmunoScape, a U.S.-Singapore

Immune Response 52

Immune Response Protein Medicine Genetics 52

Drug Discovery World

FEBRUARY 6, 2024

Technologies like artificial intelligence (AI), machine learning (ML) and robotics/automation are enabling researchers to process enormous data sets and conduct preclinical investigations in record time, speeding up the process and offering greater accuracy. Universities are also using these digital technologies to advance their research.

Marketing 69

Marketing Medicine Genome Genomics 69

Delveinsight

JULY 23, 2020

Now, a research team that is led by Monash University in Australia has searched a way to target platelet activation in a way that appears to specifically address the pathological clumping of blood without meddling with normal processes that inhibit uncontrolled bleeding.

Protein 52

Protein Bacteria Scientist Research 52

Drug Discovery World

MARCH 14, 2023

For the first time, researchers have developed an mRNA vaccine that is 100% effective against a type of bacteria that is lethal to humans, paving the way for effective vaccination against antibiotic-resistant bacteria. However, until now scientists believed that mRNA vaccines against bacteria were biologically undoable.

Bacteria 59

Bacteria Vaccination Vaccine Protein 59

Pharmaceutical Technology

AUGUST 17, 2022

Lyme disease is also known as borreliosis, which refers to the borrelia bacteria that cause the condition. The vaccine targets six different serotypes of borrelia bacteria. In the past, the volatility of the bacteria made target identification difficult. It is currently treated with antibiotics.

Vaccination 299

Vaccination Vaccine Bacteria Protein 299

Drug Discovery World

DECEMBER 29, 2023

Dr Sofia Ferreira, Director of Applications at Refeyn, discusses how various technologies can address the main challenges in membrane protein characterization, describing how novel technologies, such as mass photometry, can streamline and support analytical processes. Scientists use a multitude of membrane mimetics to overcome this issue.

Protein 52

Protein In-Vitro Research Drugs 52

Roots Analysis

OCTOBER 19, 2023

Bacteria plays a crucial role in maintaining the ecosystem balance. However, there are few species of bacteria that can cause several infectious diseases ( such as strep throat, salmonellosis, tuberculosis, whooping cough ). The overuse of antibiotics has resulted in the emergence of multi-drug-resistant bacteria. coli and P.

Bacteria 40

Bacteria Production In-Vivo In-Vitro 40

XTalks

DECEMBER 24, 2020

After being identified in December 2019 in Wuhan, Hubei in China, medical officials and scientists got to work to isolate and identify the novel virus that they observed to be causing a new respiratory illness. Most antibody drugs and vaccines have been developed to target parts of the spike protein.

Life Science 111

Life Science Vaccination Vaccine Gene 111

Drug Discovery World

NOVEMBER 28, 2023

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way.

Protein 59

Protein Drugs Reagent Life Science 59

Drug Discovery World

APRIL 30, 2024

Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has begun to expand into areas of vaccinology, infectious diseases and other indications. Its job is to carry coding information that is essential to the translation and processing of functional proteins.

RNA 52

RNA Protein Vaccination Vaccine 52

Drug Discovery World

OCTOBER 11, 2023

Dr Luke Clifton , Instrument Scientist at ISIS Neutron and Muon Source, explains the molecular mechanism behind antibiotics. Until recently, many large pharmaceutical companies had stopped antibiotic research entirely as the returns on investment were too low and regulatory requirements too stringent 5.

Bacteria 59

Bacteria Development Scientist Protein 59

Drug Discovery World

OCTOBER 4, 2022

Rebecca McClellan, Scientific Program Manager, Research, Development & Communications, explains how scientists are learning more about the connections between the microbiome and human health to potentially develop first-in-class microbiome therapies. Building the ark. Foreign invasion.

Research 52

Research Bacteria Scientist Bacterium 52

Drug Discovery World

APRIL 25, 2024

According to Grand View Research, the global cell line development market was valued at $4.81 Grand View Research states that the market for cell lines is currently bolstered by the fact that the majority of biopharma companies use cell lines to synthesise recombinant monoclonal antibodies and proteins.

Development 59

Development Protein In-Vivo Life Science 59

Drug Discovery World

AUGUST 10, 2022

But decades of research led to improvements in cancer therapy, centred around the idea that one’s immune system could aid in treatment. Their continued promise has led to an exponential increase in research on their utility, function, risks, and potential benefits. Developing the first CAR T cell therapy.

Manufacturing 98

Manufacturing Gene Genome Genomics 98

Drug Discovery World

MAY 2, 2023

Some of the most important breakthroughs in pharmaceutical research were adapted from naturally occurring phenomena. In the event of an attack from similar bacteriophages, the bacteria can recognise these segments and use this to discern and cleave the viral DNA, which disrupts the viral gene function.

Genome 52

Genome Genomics Gene DNA 52

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. The monoclonal antibody targets CD20, a protein found on the surface of B lymphocytes (B cells). The FDA approved the drug over a decade ago in September 2009.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JANUARY 21, 2021

Researchers at Washington University School of Medicine in St. The research was published in the journal JCI Insight. The research team evaluated 97 patients with COVID-19 at Barnes-Jewish Hospital. Scientists at KU Leuven have identified a biological mechanism behind irritable bowel syndrome (IBS) and other food intolerances.

Research 52

Research DNA Hormones Vaccination 52

pharmaphorum

SEPTEMBER 14, 2020

While there may be just under 20,000 confirmed protein coding genes, it turns out that much of the genome outside of these genes is also important in regulating how the genome is controlled. To address these issues, scientists and clinicians are starting to look at ‘long-read’ sequencing.

Genome 118

Genome Genomics Medicine Gene 118

Drug Discovery World

JULY 18, 2023

Years of development and fast-paced research have continued to unlock its potential, expanding how CRISPR can be used to treat, detect, and prevent common diseases such as cancer and Covid-19. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g., parvovirus B19, Flaviviridae, Ebola, and Coronaviridae), DNA viruses (e.g.,

DNA 98

DNA Genome Genomics RNA 98

Druggist

SEPTEMBER 15, 2021

Is azithromycin effective in the treatment of covid - what research says? But, the way the virus is continuously mutating, is a problem for both scientists and doctors. Recently research has revealed that these medicines doxycycline and azithromycin given to covid patients is not effective in dangerous infection.

Doctors 52

Doctors Doctor Medicine Bacteria 52

Druggist

SEPTEMBER 15, 2021

Is azithromycin effective in the treatment of covid - what research says? But, the way the virus is continuously mutating, is a problem for both scientists and doctors. Recently research has revealed that these medicines doxycycline and azithromycin given to covid patients is not effective in dangerous infection.

Doctors 52

Doctors Doctor Medicine Bacteria 52

The Pharma Data

DECEMBER 15, 2020

Researchers are aware of more than 80 diseases that occur when the immune system attacks the body’s own organs, tissues and cells. Scientists will be testing a drug class targeting the C-reactive protein (CRP) marker of acute inflammation in the body. It may be life-threatening. BioSpace has captured some key efforts.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

The Pharma Data

MAY 14, 2021

Charles River loses a battle over harvesting horseshoe crabs used for testing bacteria in drugs ( STAT ). COVID-19 lab leak theory cannot be ruled out, leading scientists say ( Reuters ). Remove barriers restricting the research of controlled drugs, says RPS ( PharmaTimes ). Medtech.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

Pharmaceutical Technology

MARCH 24, 2023

TB is caused by the bacillus Mycobacterium tuberculosis and is transmitted when infected individuals expel bacteria into the air (e.g., Researchers expect TB to soon return to its pre-2020 position as the deadliest infectious disease globally. The ID93 vaccine is being developed by the Infectious Disease Research Institute (IDRI).

Vaccination 162

Vaccination Vaccine Clinical Trials Clinical Trials 162